You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (0) |
Back to Search
A novel ULK1 agonist with cytoprotective autophagy modulation in Parkinson's disease
- In: Poster Presentation
- At: Stockholm (Sweden) (2017)
- Type: Poster
- Poster code: P-A-031-Tuesday
- By: OUYANG, Liang (Chengdu, China)
- Co-author(s): Lan Zhang: State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Collaborative Innovation Center for Biotherapy, Sichuan university, Chengdu, China
Liang Ouyang: State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Collaborative Innovation Center for Biotherapy, Sichuan University, Chengdu, China - Abstract:
Backgrounds
Autophagy is an evolutionarily conserved, multi-step lysosomal degradation process, in which a cell degrades long-lived proteins and damaged organelles. Defects in autophagy have implications for therapy of Parkinson's disease (PD), and thus activation of autophagy would be a promising strategy. UNC-51-like kinase 1(ULK1), the yeast Atg1.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026